- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma ; volume:3 ; number:1 ; day:26 ; month:7 ; year:2005 ; pages:1-15 ; date:12.2005
Journal of translational medicine ; 3, Heft 1 (26.7.2005), 1-15, 12.2005
- Creator
-
Geiger, Christiane
- Contributor
-
Regn, Sybille
Weinzierl, Andreas
Noessner, Elfriede
Schendel, Dolores J.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-3-29
- URN
-
urn:nbn:de:1111-2016041431026
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Geiger, Christiane
- Regn, Sybille
- Weinzierl, Andreas
- Noessner, Elfriede
- Schendel, Dolores J.
- SpringerLink (Online service)
Other Objects (12)
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Investigation of the Immunomodulatory effect of Berberis vulgaris on core-pulsed dendritic cell vaccine
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine
P18-10. Ability of HIV antigens-pulsed monocyte-derived dendritic cells to induce HIV-specific T cell response: potential use in therapeutic vaccine
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells
Dendritic cells
Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number
Dendritic cell therapy for neurospoagioma: Immunomodulation mediated by tumor vaccine
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells
Dendritic Cell‐Hitchhiking In Vivo for Vaccine Delivery to Lymph Nodes
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Investigation of the Immunomodulatory effect of Berberis vulgaris on core-pulsed dendritic cell vaccine
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine
P18-10. Ability of HIV antigens-pulsed monocyte-derived dendritic cells to induce HIV-specific T cell response: potential use in therapeutic vaccine
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells
Dendritic cells
Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number
Dendritic cell therapy for neurospoagioma: Immunomodulation mediated by tumor vaccine
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells
Dendritic Cell‐Hitchhiking In Vivo for Vaccine Delivery to Lymph Nodes
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Investigation of the Immunomodulatory effect of Berberis vulgaris on core-pulsed dendritic cell vaccine
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine
P18-10. Ability of HIV antigens-pulsed monocyte-derived dendritic cells to induce HIV-specific T cell response: potential use in therapeutic vaccine
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells
Dendritic cells
Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number
Dendritic cell therapy for neurospoagioma: Immunomodulation mediated by tumor vaccine
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells